Saidal-Sonifarm suspicious deal inflected 3.5 bln loss to treasury, investigators

Investigators in charge of the case of “Saidal and Sonifarm,” concluded that the public treasury inflected a 3.5 billion dinars loss (3.5 million Euros) due to a suspicious deal between the two aforementioned pharmaceutical firms’ managers.

Investigators in charge of the case of “Saidal and Sonifarm,” concluded that the public treasury inflected a 3.5 billion dinars loss (3.5 million Euros) due to a suspicious deal between the two aforementioned pharmaceutical firms’ managers.

The case goes back to the fall of 2004, when state-run pharmaceutical company Saidal and private firm Sonifarm struck a 3.5 billion dinars deal to produce teeth-whitening pills for children baptized “Donfluor”. Yet the project has not been launched since then. The public treasury inflected a 3.5 billion dinars loss, following a suspicious deal sealed by private agreement by former CEO of Saidal and the CEO of SoniFarm, who are both in prison pending investigation.

To recall, the investigation is being conducted by Finance General Inspection (IGF).